Topics

Confirmed: OS Better With Immunotherapy in Small Cell Lung Cancer

13:29 EDT 13 Sep 2019 | Medscape

A second study supports the benefit of adding an immune checkpoint inhibitor to standard chemotherapy for extensive stage, small cell lung cancer — with little additional toxicity.
Medscape Medical News

Original Article: Confirmed: OS Better With Immunotherapy in Small Cell Lung Cancer

NEXT ARTICLE

More From BioPortfolio on "Confirmed: OS Better With Immunotherapy in Small Cell Lung Cancer"

Quick Search

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...